Amy Moss Trombly - 02 Jan 2026 Form 4 Insider Report for Sonoma Pharmaceuticals, Inc. (SNOA)

Role
Chief Executive Officer
Signature
/s/ Amy Trombly
Issuer symbol
SNOA
Transactions as of
02 Jan 2026
Net transactions value
$0
Form type
4
Filing time
02 Jan 2026, 17:24:16 UTC
Previous filing
20 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Trombly Amy Moss Chief Executive Officer C/O SONOMA PHARMACEUTICALS, INC., 5445 CONESTOGA COURT, SUITE 150, BOULDER /s/ Amy Trombly 02 Jan 2026 0001384640

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNOA Restricted Stock Units Award $0 +10,000 +31% $0.000000 42,185 02 Jan 2026 Common Stock 10,000 $0.000000 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock.
F2 The RSUs vest on the third anniversary of the grant date, or upon change of control.
F3 The RSUs were awarded and granted to Ms. Trombly for services performed.